LONDON (Reuters) - Britain's Orchard Therapeutics, which has already raised more than $140 million to fund its work in gene therapy, plans another private sale of shares following its acquisition of a portfolio of GlaxoSmithKline rare disease …
Yahoo!1mon
GlaxoSmithKline PLC (GSK.LN) said Wednesday that net profit fell 48% as revenue declined on currency headwinds in the first quarter, and said that it backed its full-year guidance. The pharmaceutical company said that net profit for the …
LONDON (Reuters) - Britain’s Orchard Therapeutics, which has already raised more than $140 million (98.54 million pounds) to fund its work in gene therapy, plans another private sale of shares following its acquisition of a portfolio of …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …